Jazz Pharmaceuticals’ CBD drug shows promise beyond seizure reduction
The survey focused on patients receiving Epidiolex, along with clobazam, for at least three months.
The post Jazz Pharmaceuticals’ CBD drug shows promise beyond seizure reduction appeared first on Green Market Report.
